Incorporation of nitric oxide donor into 1,3-dioxyxanthones leads to synergistic anticancer activity.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European journal of medicinal chemistry

• Publication date

  2018-05-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2018.03.072PMID 29609121
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis of xanthone derivatives and studies on the inhibition against cancer cells growth and synergistic combinations of them.

  2017cited by this paper
• Design, synthesis and biological evaluation of novel nitric oxide-donating protoberberine derivatives as antitumor agents.

  2017cited by this paper
• Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.

  2016cited by this paper
• Microwave-Assisted Organocatalytic Intramolecular Knoevenagel/Hetero Diels-Alder Reaction with O-(Arylpropynyloxy)-Salicylaldehydes: Synthesis of Polycyclic Embelin Derivatives.

  2016cited by this paper
• Medicinal Chemistry Strategies to Disrupt the p53–MDM2/MDMX Interaction

  2016cited by this paper
• Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument.

  2016cited by this paper
• Oleanolic acid-NO donor-platinum(II) trihybrid molecules: Targeting cytotoxicity on hepatoma cells with combined action mode and good safety.

  2016cited by this paper
• Synthesis of CDDO-amino acid-nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer.

  2015cited by this paper
• Novel nitric oxide generating compound glycidyl nitrate enhances the therapeutic efficacy of chemotherapy and radiotherapy.

  2014cited by this paper
• Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach.

  2013cited by this paper
• Hepatocellular carcinoma

  2012cited by this paper
• Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma.

  2012cited by this paper
• Structure-based design of novel inhibitors of the MDM2-p53 interaction.

  2012cited by this paper
• Small molecule agents targeting the p53‐MDM2 pathway for cancer therapy

  2012cited by this paper
• Hepatocellular carcinoma.

  2011cited by this paper
• Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NO

  2011cited by this paper
• Molecular modeling approaches in the discovery of new drugs for anti-cancer therapy: the investigation of p53-MDM2 interaction and its inhibition by small molecules.

  2010cited by this paper
• Regulation of the Apaf-1–caspase-9 apoptosome

  2010cited by this paper
• Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer.

  2010cited by this paper
• A new short synthesis of 5,6-dimethylxanthenone-4-acetic acid (ASA404, DMXAA)

  2009cited by this paper
• NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells.

  2008cited by this paper
• Chemosensitization of cancer by nitric oxide.

  2008cited by this paper
• ASA404: update on drug development.

  2008cited by this paper
• Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases.

  2008cited by this paper
• Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death

  2006cited by this paper
• The role of nitric oxide in tumour progression

  2006cited by this paper
• Nitric oxide reverts the resistance to doxorubicin in human colon cancer cells by inhibiting the drug efflux.

  2005cited by this paper
• Oxidative Stress and Mitochondrial Aldehyde Dehydrogenase Activity: A Comparison of Pentaerythritol Tetranitrate with Other Organic Nitrates

  2004cited by this paper
• Nitric oxide's reactions with hemoglobin: a view through the SNO-storm

  2003cited by this paper
• In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase, tumour necrosis factor-alpha and transforming growth factor-beta genes.

  2003cited by this paper
• Synthesis of 3'- and 5'-nitrooxy pyrimidine nucleoside nitrate esters: "nitric oxide donor" agents for evaluation as anticancer and antiviral agents.

  2003cited by this paper
• Reactions of PTIO and carboxy-PTIO with *NO, *NO2, and O2-*.

  2003cited by this paper
• Antivascular therapy of cancer: DMXAA.

  2003cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Identification of the enzymatic mechanism of nitroglycerin bioactivation

  2002cited by this paper
• NO donors with anticancer activity

  2002cited by this paper
• Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis.

  2002cited by this paper
• Emerging roles of caspase-3 in apoptosis

  1999cited by this paper
• Antitumor, immunomodulatory and anti-HIV effect of mangiferin, a naturally occurring glucosylxanthone.

  1996cited by this paper
• Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

  1995cited by this paper
• Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

  1994cited by this paper
• Human mitochondrial aldehyde dehydrogenase inhibition by diethyldithiocarbamic acid methanethiol mixed disulfide: a derivative of disulfiram

  1985cited by this paper

• Design, synthesis and antitumor study of novel NO-type porphyrin–ferulic acid derivatives for chemotherapy and photodynamic therapy

  2024cites this paper
• Scope and limitations of the preparation of xanthones using Eaton’s reagent

  2023cites this paper
• Xanthones as potential α‐glucosidase non‐competition inhibitors: Synthesis, inhibitory activities, and in silico studies

  2023cites this paper
• Total synthesis of (±)-chaetoxanthone B

  2021cites this paper
• Design, Synthesis, In Silico and In Vitro Studies for New Nitric Oxide-Releasing Indomethacin Derivatives with 1,3,4-Oxadiazole-2-thiol Scaffold

  2021cites this paper
• Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease.

  2021cites this paper
• New nitric oxide-releasing indomethacin derivatives with 1,3-thiazolidine-4-one scaffold: Design, synthesis, in silico and in vitro studies.

  2021cites this paper
• Metabolites of Lycium barbarum L. from Lactobacillus acidophilus as Anti-hepatocellular carcinoma agents: induce apoptosis

  2020cites this paper
• Design, synthesis and apoptosis-related antiproliferative activities of chelidonine derivatives.

  2019cites this paper
• Retracted Article: Synthesis of xanthone derivatives and anti-hepatocellular carcinoma potency evaluation: induced apoptosis

  2019cites this paper